Free Trial

Chemed Co. (NYSE:CHE) Shares Purchased by Loomis Sayles & Co. L P

Chemed logo with Medical background
Remove Ads

Loomis Sayles & Co. L P increased its holdings in Chemed Co. (NYSE:CHE - Free Report) by 25.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,462 shares of the company's stock after acquiring an additional 7,303 shares during the quarter. Loomis Sayles & Co. L P owned approximately 0.24% of Chemed worth $19,317,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new stake in shares of Chemed in the 4th quarter valued at about $42,023,000. HighTower Advisors LLC boosted its stake in Chemed by 78.0% in the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock worth $2,246,000 after purchasing an additional 1,634 shares in the last quarter. XTX Topco Ltd grew its holdings in shares of Chemed by 111.5% during the third quarter. XTX Topco Ltd now owns 2,843 shares of the company's stock valued at $1,709,000 after buying an additional 1,499 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after purchasing an additional 15,791 shares during the period. Finally, Signal Advisors Wealth LLC raised its position in Chemed by 60.7% during the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock worth $2,647,000 after buying an additional 1,886 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.

Remove Ads

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 3.32% of the company's stock.

Chemed Stock Performance

Shares of CHE traded down $0.11 during trading hours on Wednesday, hitting $618.46. 43,299 shares of the stock were exchanged, compared to its average volume of 94,295. The stock's 50-day moving average price is $576.54 and its two-hundred day moving average price is $567.29. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $639.61. The company has a market cap of $9.05 billion, a price-to-earnings ratio of 31.25, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's dividend payout ratio (DPR) is 10.05%.

Analysts Set New Price Targets

CHE has been the subject of several analyst reports. Royal Bank of Canada boosted their price objective on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a report on Friday, March 14th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Read Our Latest Analysis on CHE

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads